Pediatric nonalcoholic fatty liver disease and the microbiome: Mechanisms contributing to pathogenesis and...

Area of Science:

• Pediatric Gastroenterology and Hepatology
• Microbiome Research
• Metabolic Syndrome Studies

Background:

• Nonalcoholic fatty liver disease (NAFLD) is the most prevalent pediatric liver condition in the U.S.
• NAFLD spectrum ranges from steatosis to cirrhosis, driven by multi-modal liver injury.
• Obesity and metabolic syndrome are frequent comorbidities of pediatric NAFLD.

Purpose of the Study:

• To review the current understanding of the intestinal microbiome's role in pediatric NAFLD.
• To identify common mechanisms between microbiome-associated inflammatory diseases and NAFLD.
• To explore potential therapeutic interventions targeting the microbiome for NAFLD.

Main Methods:

• Literature review of pediatric studies on the intestinal microbiome and NAFLD.
• Analysis of existing data regarding microbiome composition and function in pediatric NAFLD.
• Synthesis of findings to understand disease pathophysiology and progression.

Main Results:

• Pediatric studies on the gut microbiome in NAFLD are limited and show design inconsistencies.
• Despite limitations, evidence suggests the intestinal microbiome is involved in NAFLD development.
• Shared mechanisms with other inflammatory diseases highlight microbiome's potential therapeutic relevance.

Conclusions:

• The intestinal microbiome is implicated in pediatric NAFLD pathophysiology.
• Further standardized research is needed to clarify the microbiome's precise role.
• Targeting the gut microbiome may offer novel therapeutic strategies for pediatric NAFLD.